Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

66.70
-0.9800-1.45%
Post-market: 66.41-0.2900-0.43%19:30 EDT
Volume:1.59M
Turnover:106.77M
Market Cap:12.89B
PE:176.00
High:68.34
Open:67.55
Low:66.52
Close:67.68
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:0.90
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.04
PE(LYR):37.06

Loading ...

OverviewCompanyNewsFilings

BioMarin to Attend Four Investor Conferences in March

Reuters
·
Feb 24

Evercore ISI Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Feb 24

Cantor Fitzgerald Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Feb 24

Biomarin Pharmaceutical Q4 Adj. EPS $0.46 Misses $0.63 Estimate, Sales $875.000M Beat $827.969M Estimate

Benzinga Earnings
·
Feb 24

BioMarin Q4 net income swings to a GAAP net loss of USD 47 million on 17% revenue growth to USD 875 million

Reuters
·
Feb 24

BRIEF-Biomarin Pharmaceutical Q4 EPS USD -0.24

Reuters
·
Feb 24

Biomarin Pharmaceutical Q4 Adjusted EPS USD 0.46 VS. Ibes Estimate USD 0.62

THOMSON REUTERS
·
Feb 24

Biomarin Pharmaceutical Outlook FY Adj EPS $4.95 to $5.15

THOMSON REUTERS
·
Feb 24

Biomarin Pharmaceutical Inc Outlook FY Total Revenues $3,325 Mln to $3,425 Mln

THOMSON REUTERS
·
Feb 24

Biomarin Pharmaceutical Inc FY2026 Shr View $4.50, REV View $3.52 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Feb 24

BioMarin options imply 7.4% move in share price post-earnings

TIPRANKS
·
Feb 24

Analyst Rate

Buy
Buy
75.87%
Hold
24.14%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Post-Mkt
Financial Report Announcement
May 04, 2026 Post-Mkt
Financial Report Announcement
Feb 23, 2026 Post-Mkt
Financial Report Announcement
Oct 27, 2025 Post-Mkt
Financial Report Announcement
Aug 04, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

176.00
Current
160.58
Sector Average
71.69%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
176.00
Maximum
1,055.05
+1 STD
412.37
Minimum
-246.96
-1 STD
-91.21
Average
160.58

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.